NCT04595565 2026-04-22
SASCIA
GBG Forschungs GmbH
Phase 3 Active not recruiting
Clinical Trials
6 trialsNCT03971409 2026-04-17
InCITe
University of California, San Francisco
Phase 2 Active not recruiting
NCT05382299 2026-04-06
ASCENT-03
Gilead Sciences
Phase 3 Active not recruiting
NCT04454437 2026-02-02
Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments
Gilead Sciences
Phase 2 Active not recruiting
NCT05382286 2025-09-18
ASCENT-04
Gilead Sciences
Phase 3 Active not recruiting
NCT05101096 2025-03-25
ASCENT-J02
Gilead Sciences
Phase 1/2 Active not recruiting